Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HOUS
10401
CALL
DELISTED
Anywhere Real Estate
HOUS
| $202K | ﹤0.01% |
61,300
-115,300
| -65% | -$494K |
2018 Q3
25 quarters
|
|
|
AVB
10402
DELISTED
AvalonBay Communities
AVB
| $202K | ﹤0.01% |
919
-618,288
| -100% | -$140M |
2021 Q3
13 quarters
|
|
10403
Citizens Community Bancorp
CZWI
$204M
| $202K | ﹤0.01% |
+12,404
| New | +$189K |
2024 Q4
0 quarters
|
|
10404
PUT
Progress Software
PRGS
$1.59B
| $202K | ﹤0.01% |
3,100
-40,700
| -93% | -$2.72M |
2022 Q4
8 quarters
|
|
10405
CALL
iShares MSCI Spain ETF
EWP
$2.33B
| $202K | ﹤0.01% |
6,500
+100
| +2% | +$3.32K |
2024 Q1
3 quarters
|
|
10406
PUT
Invesco Preferred ETF
PGX
$3.58B
| $202K | ﹤0.01% |
17,500
+17,400
| +17,400% | +$209K |
2023 Q1
7 quarters
|
|
10407
Global X US Cash Flow Kings 100 ETF
FLOW
$33.1M
| $202K | ﹤0.01% |
+6,427
| New | +$208K |
2024 Q4
0 quarters
|
|
10408
Invesco DB Agriculture Fund
DBA
$1.23B
| $202K | ﹤0.01% |
7,584
-37,941
| -83% | -$991K |
2022 Q4
8 quarters
|
|
|
SLSR
10409
Solaris Resources
SLSR
$1.15B
| $202K | ﹤0.01% |
64,939
+29,015
| +81% | +$78.3K |
2024 Q3
1 quarter
|
|
|
APLT
10410
PUT
DELISTED
Applied Therapeutics
APLT
| $201K | ﹤0.01% |
235,300
+216,300
| +1,138% | +$1.36M |
2023 Q2
6 quarters
|
|
10411
PUT
Magnachip Semiconductor
MX
$112M
| $201K | ﹤0.01% |
50,100
+6,900
| +16% | +$29.4K |
2021 Q4
12 quarters
|
|
10412
PUT
Boston Omaha
BOC
$388M
| $201K | ﹤0.01% |
14,200
+7,600
| +115% | +$113K |
2022 Q4
8 quarters
|
|
10413
INVE Technologies, Inc. Common Stock
INVE
$58.7M
| $201K | ﹤0.01% |
54,990
-8,737
| -14% | -$32.7K |
2022 Q4
8 quarters
|
|
|
OTLY
10414
Oatly Group
OTLY
$337M
| $201K | ﹤0.01% |
15,182
+3,393
| +29% | +$50K |
2023 Q4
4 quarters
|
|
10415
PUT
Zevra Therapeutics
ZVRA
$674M
| $201K | ﹤0.01% |
24,100
-18,900
| -44% | -$161K |
2021 Q1
15 quarters
|
|
10416
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $201K | ﹤0.01% |
8,299
-24,208
| -74% | -$591K |
2024 Q3
1 quarter
|
|
|
NTRL
10417
First Trust Equity Market Neutral ETF
NTRL
$14.4M
| $201K | ﹤0.01% |
+10,094
| New | +$200K |
2024 Q4
0 quarters
|
|
10418
ProShares UltraShort MidCap400
MZZ
$4.56M
| $201K | ﹤0.01% |
+20,589
| New | +$193K |
2024 Q4
0 quarters
|
|
10419
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$134M
| $201K | ﹤0.01% |
4,511
-20,979
| -82% | -$945K |
2024 Q3
1 quarter
|
|
|
RFEU
10420
DELISTED
First Trust RiverFront Dynamic Europe ETF
RFEU
| $200K | ﹤0.01% |
3,388
-9
| -0.3% | -$567 |
2024 Q3
1 quarter
|
|
10421
Innovator US Small Cap Power Buffer ETF July
KJUL
$228M
| $200K | ﹤0.01% |
+6,805
| New | +$201K |
2024 Q4
0 quarters
|
|
10422
PUT
NCR Atleos
NATL
$3.39B
| $200K | ﹤0.01% |
5,900
-42,850
| -88% | -$1.3M |
2023 Q4
4 quarters
|
|
10423
Brookstone Opportunities ETF
BAMO
$44.6M
| $200K | ﹤0.01% |
+6,600
| New | +$201K |
2024 Q4
0 quarters
|
|
|
FYLG
10424
DELISTED
Global X Financials Covered Call & Growth ETF
FYLG
| $200K | ﹤0.01% |
+7,051
| New | +$201K |
2024 Q4
0 quarters
|
|
|
ORGN
10425
PUT
DELISTED
Origin Materials
ORGN
| $200K | ﹤0.01% |
5,207
-2,113
| -29% | -$80.2K |
2021 Q1
15 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.